209 related articles for article (PubMed ID: 1332992)
21. Inhibition of concomitant thrombin-mediated fibrin formation enhances clot lysis in whole blood.
Haskel EJ; Eisenberg PR; Abendschein DR
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):7-13. PubMed ID: 8457655
[TBL] [Abstract][Full Text] [Related]
22. [Heparin-induced impairment of thrombin interaction with fibrinogen and receptors of the anti-coagulation system].
Strukova SM; Umarova BA; Kulibali M
Vopr Med Khim; 1986; 32(3):132-6. PubMed ID: 3014736
[TBL] [Abstract][Full Text] [Related]
23. Low molecular weight heparin (dalteparin) is equally effective as unfractionated heparin in reducing coagulation activity and perfusion abnormalities during the early treatment of pulmonary embolism.
Schutgens RE; Esseboom EU; Snijder RJ; Haas FJ; Verzijlbergen F; Nieuwenhuis HK; Lisman T; Biesma DH
J Lab Clin Med; 2004 Aug; 144(2):100-7. PubMed ID: 15322504
[TBL] [Abstract][Full Text] [Related]
24. [The effect of aminazine on blood coagulation].
Novak EN
Farmakol Toksikol; 1972; 35(6):717-20. PubMed ID: 4651808
[No Abstract] [Full Text] [Related]
25. Anticoagulant mechanisms of covalent antithrombin-heparin investigated by thrombelastography. Comparison with unfractionated heparin and low-molecular-weight heparin.
Atkinson HM; Mewhort-Buist TA; Berry LR; Chan AK
Thromb Haemost; 2009 Jul; 102(1):62-8. PubMed ID: 19572069
[TBL] [Abstract][Full Text] [Related]
26. [Electron microscopic study of the products from dissolving unstabilized fibrin with complex heparin compounds].
Ul'ianov AM; Zhitnikova ES
Biokhimiia; 1978; 43(4):646-52. PubMed ID: 656495
[TBL] [Abstract][Full Text] [Related]
27. [The role of the antithrombin III-heparin-thrombin complex in the defense reaction of the anticoagulation system].
Kudriashov BA; Liapina LA; Pastorova VE
Vopr Med Khim; 1988; 34(2):38-42. PubMed ID: 3400189
[TBL] [Abstract][Full Text] [Related]
28. [Role of the substrate-binding portion of the active center of alpha-thrombin in excitation of the secondary anticoagulating system].
Kudriashov BA; Umarova BA; Strukova SM; Liapina LA
Dokl Akad Nauk SSSR; 1979; 248(2):485-8. PubMed ID: 487934
[No Abstract] [Full Text] [Related]
29. [The heparin-epinephrine complex as humoral factor in the anticoagulatory system].
Kudrjashov BA; Liapina LA
Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(3):272-84. PubMed ID: 4106019
[No Abstract] [Full Text] [Related]
30. [Use of reptilase-thrombin as a reagent for the determination of fibrinogen].
Baumgartner G
Wien Klin Wochenschr; 1971 Nov; 83(45):829-32. PubMed ID: 5167574
[No Abstract] [Full Text] [Related]
31. Effects of fibrinolytic inhibitors and heparin on induced intravascular coagulation.
Nordström S
Acta Physiol Scand Suppl; 1970; 337():1-35. PubMed ID: 5311663
[No Abstract] [Full Text] [Related]
32. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia.
Sauls DL; Lockhart E; Warren ME; Lenkowski A; Wilhelm SE; Hoffman M
Biochemistry; 2006 Feb; 45(8):2480-7. PubMed ID: 16489740
[TBL] [Abstract][Full Text] [Related]
33. Effects of thrombin infusions upon 131-I-labelled fibrinogen in dogs.
Nordström S; Zetterqvist E
Acta Physiol Scand; 1968; 72(1):85-99. PubMed ID: 5301454
[No Abstract] [Full Text] [Related]
34. Affects of hirudin and heparin on the binding of new fibrin to the thrombus in t-PA treated rabbits.
Agnelli G; Pascucci C; Cosmi B; Nenci GG
Thromb Haemost; 1991 Nov; 66(5):592-7. PubMed ID: 1839474
[TBL] [Abstract][Full Text] [Related]
35. Modulation of blood coagulation and fibrinolysis by polyamines in the presence of glycosaminoglycans.
Homma R; Mase A; Toida T; Kashiwagi K; Igarashi K
Int J Biochem Cell Biol; 2005 Sep; 37(9):1911-20. PubMed ID: 15936241
[TBL] [Abstract][Full Text] [Related]
36. Activation of coagulation and fibrinolysis in microsurgical reconstructions in the lower extremities.
Olsson E; Svartling N; Asko-Seljavaara S; Lassila R
Br J Plast Surg; 2001 Oct; 54(7):597-603. PubMed ID: 11583496
[TBL] [Abstract][Full Text] [Related]
37. Human thrombin and calcium bound factor Xa significantly shorten tPA-induced fibrin clot lysis time via neutralization of plasminogen activator inhibitor type 1 activity.
Urano T; Nagai N; Matsuura M; Ihara H; Takada Y; Takada A
Thromb Haemost; 1998 Jul; 80(1):161-6. PubMed ID: 9684803
[TBL] [Abstract][Full Text] [Related]
38. Effects of low molecular weight heparins on fibrin polymerization and clot sensitivity to t-PA-induced lysis.
Parise P; Morini M; Agnelli G; Ascani A; Nenci GG
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):721-7. PubMed ID: 8292721
[TBL] [Abstract][Full Text] [Related]
39. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
[TBL] [Abstract][Full Text] [Related]
40. Studies on the action mechanism of the antihemostatic effect of lodopeptides.
Golub AL; Mende TJ
Thromb Haemost; 1976 Apr; 35(2):437-46. PubMed ID: 9704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
